SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-017709
Filing Date
2017-03-30
Accepted
2017-03-30 16:28:27
Documents
55
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v462622_10k.htm 10-K 672214
2 EXHIBIT 21 v462622_ex21.htm EX-21 1710
3 EXHIBIT 23.1 v462622_ex23-1.htm EX-23.1 2490
4 EXHIBIT 31.1 v462622_ex31-1.htm EX-31.1 10720
5 EXHIBIT 31.2 v462622_ex31-2.htm EX-31.2 11417
6 EXHIBIT 32 v462622_ex32.htm EX-32 5095
  Complete submission text file 0001144204-17-017709.txt   5162871

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT accp-20161231.xml EX-101.INS 1065985
8 XBRL TAXONOMY EXTENSION SCHEMA accp-20161231.xsd EX-101.SCH 37865
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE accp-20161231_cal.xml EX-101.CAL 66573
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE accp-20161231_def.xml EX-101.DEF 237327
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE accp-20161231_lab.xml EX-101.LAB 640025
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE accp-20161231_pre.xml EX-101.PRE 370527
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 17726106
SIC: 2834 Pharmaceutical Preparations